NPI 1821007808: Open Payments
NPI 1821007808. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164 in 7 payments from 3 companies in 2025. Trend: 2023 $99 · 2024 $75 · 2025 $164
Food & beverage: $164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $88 |
| Novo Nordisk Inc | 2 | $40 |
| Galderma Laboratories, L.P. | 2 | $36 |
Products named: BOTOX, Ozempic.
